Induction therapy results
| . | Placebo . | PEG-rHuMGDF (μg/kg/d) . | |
|---|---|---|---|
| 2.5 . | 5 . | ||
| Age, below 60 y | |||
| n | 11 | 12 | 12 |
| Complete remission, % of total | 9 (82%) | 7 (58%) | 9 (75%) |
| Median days to platelet recovery (≥ 20 × 109/L) | 28 | 30 | 30 |
| Median days of platelet transfusion | 8 | 7 | 10 |
| Age, at least 60 y | |||
| n | 8 | 7 | 7 |
| Complete remission, % of total | 4 (50%) | 5 (71%) | 5 (71%) |
| Median days to platelet recovery (≥ 20 × 109/L) | 22 | 23 | 21 |
| Median days of platelet transfusion | 5 | 5 | 6 |
| . | Placebo . | PEG-rHuMGDF (μg/kg/d) . | |
|---|---|---|---|
| 2.5 . | 5 . | ||
| Age, below 60 y | |||
| n | 11 | 12 | 12 |
| Complete remission, % of total | 9 (82%) | 7 (58%) | 9 (75%) |
| Median days to platelet recovery (≥ 20 × 109/L) | 28 | 30 | 30 |
| Median days of platelet transfusion | 8 | 7 | 10 |
| Age, at least 60 y | |||
| n | 8 | 7 | 7 |
| Complete remission, % of total | 4 (50%) | 5 (71%) | 5 (71%) |
| Median days to platelet recovery (≥ 20 × 109/L) | 22 | 23 | 21 |
| Median days of platelet transfusion | 5 | 5 | 6 |